Clinical Microbiology and Infection

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Molecular evolution of Mycobacterium tuberculosis

New epidemiology of Staphylococcus aureus infection in Asia

Benchmarking inappropriate empirical antibiotic treatment

Metagenomics and antibiotics

G. Cornaglia, A. Lönnroth, M. Struelens

Gut bacterial microbiota and obesity

O.J. Dyar, G. Tebano, C. Pulcini Clinical Microbiology and Infection

Changes in the intestinal microbiota from adulthood through to old age

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

Invasive group A, B, C and G streptococcal infections in Denmark 1999–2002: epidemiological and clinical aspects K. Ekelund, P. Skinhøj, J. Madsen, H.B.

Genomics of epidemic pathogens

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

A.K. Reddy, P. Garg, I. Kaur Clinical Microbiology and Infection

J.-P. Van geertruyden Clinical Microbiology and Infection

Public health microbiology, a challenge for Europe

R. Cantón Clinical Microbiology and Infection

Louis Pasteur, from crystals of life to vaccination

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

F. Grosso, S. Quinteira, L. Peixe Clinical Microbiology and Infection

Genetic association of blaSHV-5 with transposable elements IS26 and IS5 in Klebsiella pneumoniae from Taiwan W.L. Yu, S.C. Chen, S.W. Hung, Y.C. Chuang,

Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Vector control: a cornerstone in the malaria elimination campaign

Molecular mechanism of gentamicin resistance in Bartonella henselae

Switch to oral antibiotics in the treatment of infective endocarditis is not associated with increased risk of mortality in non–severely ill patients

Training for the infectious diseases speciality in Norway

Laboratory diagnosis and biosafety issues of biological warfare agents

CMI editorial report 2011 Clinical Microbiology and Infection

Clinical and microbiological characteristics of Nocardiosis including those caused by emerging Nocardia species in Taiwan, 1998–2008 C.-K. Tan, C.-C.

Elements of design: the knowledge on which we build

Environmental stress and evolvability in microbial systems

Population structure analyses of Staphylococcus aureus at Tygerberg Hospital, South Africa, reveals a diverse population, a high prevalence of Panton–Valentine.

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Levofloxacin in the treatment of ventilator-associated pneumonia

Evolving epidemiology of invasive Haemophilus infections in the post-vaccination era: results from a long-term population-based study M.R. Berndsen,

Metagenomics and probiotics

Effect of antioxidants on the immune response of Helicobacter pylori

Previously unknown species of Aspergillus

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Systematic review of antibiotic consumption in acute care hospitals

P. Mullany, E. Allan, P.J. Warburton

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Abstracts cont. Clinical Microbiology and Infection

Benchmarking inappropriate empirical antibiotic treatment

Antimicrobial drug development – the past, the present, and the future

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Clinical infection services—the Leiden experience

An after-hours clinical liaison blood culture service—is it worth it?

Clinical Microbiology and Infection

I. Bitar, A. Piazza Clinical Microbiology and Infection

K. Kaier, N.T. Mutters, U. Frank Clinical Microbiology and Infection

The atypical pneumonias: clinical diagnosis and importance

J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin

Abstracts Clinical Microbiology and Infection

Virology: a scientific discipline facing new challenges

Modelling during an emergency: the 2009 H1N1 influenza pandemic

New oral cephalosporins in pediatric community-acquired infections

W. Witte Clinical Microbiology and Infection

B.A. Cunha Clinical Microbiology and Infection

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

CMI readers' survey Clinical Microbiology and Infection

The future of diagnostic bacteriology

Presentation transcript:

Clinical Microbiology and Infection Metagenomic epidemiology: a public health need for the control of antimicrobial resistance F. Baquero Clinical Microbiology and Infection Volume 18, Pages 67-73 (July 2012) DOI: 10.1111/j.1469-0691.2012.03860.x Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 1 Universal processes in biological units. These processes are valid for evolutionary individuals (evolutionary units) at any level of the genetical hierarchy, from metagenomes to species, clones, mobile genetic elements, genes or modular genetic sequences; and possibly for operational taxonomic units, such as those that might be based on barcoding data. Vertical rectangles represent individuals recombining or associating with the horizontal rectangles. Clinical Microbiology and Infection 2012 18, 67-73DOI: (10.1111/j.1469-0691.2012.03860.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions

FIG. 2 Multilevel metagenomic epidemiology. Small circles represent evolutionary individuals (evolutionary units) that constitute populations (large circles). Arrows indicate possible evolutionary trajectories constituted by trans-hierarchical interactions between evolutionary units. High risk interactions are those that might give rise to a particularly successful combination able to disseminate or perpetuate antibiotic resistance, and therefore should be targeted by public health epidemiology. Clinical Microbiology and Infection 2012 18, 67-73DOI: (10.1111/j.1469-0691.2012.03860.x) Copyright © 2012 European Society of Clinical Infectious Diseases Terms and Conditions